📊 Statistics
- Analyst 1 Year Price Target:
-
- Upside/Downside from Analyst Target:
-
- Broker Call:
-
- Dividend Minimum 3 Year Yield:
0.00%
- EPS Growth Range (1Y):
-
- Net Income Growth Range (1Y):
-
- Revenue Growth Range (1Y):
-
-
Upcoming Earnings Date:
-
💰 Dividend History
Current year to date yield:
0.00%
Amount: $0.000000
Yield: -
Pay Date: -
Details:
Ratio: 2:1
📅 SGX Earnings Announcements for 1H3
Clearbridge Health Limited (1H3)
Market: SGX |
Currency: SGD
Address: 37 Jalan Pemimpin
Clearbridge Health Limited, an investment holding company, provides healthcare solutions in Singapore, the Philippines, Hong Kong, Malaysia, and internationally. It operates through Strategic Investments, Healthcare Systems, and Medical Clinics/Centres segments. The company provides imaging services, including general x-ray, computerized tomography scan, dental cone beam CT scan, mammography, magnetic resonance imaging, and ultrasound; general health services, such as diabetes, high blood pressure, and high cholesterol screening; and vaccination services, as well as renal care and clinical services. It also offers aesthetics, and dental and orthodontics services, as well as consultancy services for healthcare organization; and wholesales medicinal and pharmaceutical products. Clearbridge Health Limited was incorporated in 2010 and is based in Singapore.
Show more
📈 Clearbridge Health Limited Historical Chart
🧾 Recent Financial Statement Analysis
January 23, 2026
Clearbridge Health Limited: Lapse of Term Sheet for Proposed Acquisition of Elpis Biopharmaceuticals Clearbridge Health Limited Announces Lapse of Term Sheet for Proposed Acquisition of Elpis Biopharmaceuticals Key Highlights for Investors Lapse of Acquisition Term Sheet: Clearbridge Health Limited (“the…
November 13, 2025
Clearbridge Health Limited - Detailed Use of Placement Proceeds Clearbridge Health Limited Announces Detailed Use of Placement Proceeds Date: 13 November 2025 Key Highlights Successful Placement: Clearbridge Health Limited ("the Company") has completed a significant placement of 990,000,000 new ordinary…
October 6, 2025
Clearbridge Health Extends Convertible Bond Maturity: What Investors Must Know About This Strategic Move Clearbridge Health Extends Convertible Bond Maturity: What Investors Must Know About This Strategic Move Key Points for Investors Clearbridge Health Limited ("CBH") has announced a significant…
August 18, 2025
Clearbridge Health Completes Massive Share Placement and Warrant Issue Clearbridge Health Completes Massive Share Placement with Free Warrants: What Retail Investors Must Know Key Highlights from the Announcement Clearbridge Health Limited has successfully completed a major placement of 990,000,000 new…
August 18, 2025
Clearbridge Health Completes Massive Share Placement and Warrant Issue: What Retail Investors Must Know Clearbridge Health Completes Massive Share Placement and Warrant Issue: What Retail Investors Must Know Key Highlights of the Announcement Clearbridge Health Limited has finalized a major…
December 11, 2024
Clearbridge Health's Major Share Expansion: What Investors Need to Know Clearbridge Health's Major Share Expansion: What Investors Need to Know Clearbridge Health Limited has announced a significant development in its capital structure through a renounceable non-underwritten rights issue. The company…
December 11, 2024
Clearbridge Health's Strategic Rights Issue: A Financial Game-Changer Clearbridge Health's Strategic Rights Issue: A Financial Game-Changer Clearbridge Health Limited is making a bold move with its recent announcement of a Rights Issue, which could significantly impact its share price and…
November 20, 2024
Clearbridge Health Limited Financial Analysis - Q3FY24 Clearbridge Health Limited Financial Analysis - Q3FY24 Business Description Clearbridge Health Limited is incorporated in the Republic of Singapore. The company, along with its subsidiaries, operates in the healthcare sector focusing on providing…
November 19, 2024
Clearbridge Health's Rights Issue: Strategic Move or Risky Bet? Clearbridge Health's Rights Issue: Strategic Move or Risky Bet? Clearbridge Health Limited has announced a rights issue, aiming to raise up to S\$2,308,000. This move is designed to bolster the company's…
November 19, 2024
Clearbridge Health's Bold Rights Issue: What Investors Need to Know Clearbridge Health Limited has announced a significant move aimed at bolstering its capital structure through a proposed renounceable non-underwritten rights issue of up to 1,279,125,560 new ordinary shares. This strategic…
🔎 View more in SGX corporate News 🔎 View more in SGX Financial statements
📰 Related News & Research
Showing results matched by any of: 1H3, Clearbridge Health Limited, Clearbridge, CBH SP, CLEARBRIDGE HEALTH LTD, CLEARBRIDGE HEALTH
January 23, 2026
Clearbridge Health Limited: Lapse of Term Sheet for Proposed Acquisition of Elpis Biopharmaceuticals Clearbridge Health Limited Announces Lapse of Term Sheet for Proposed Acquisition of Elpis Biopharmaceuticals Key Highlights for Investors Lapse of Acquisition Term Sheet: Clearbridge Health Limited (“the…
November 13, 2025
Clearbridge Health Limited - Detailed Use of Placement Proceeds Clearbridge Health Limited Announces Detailed Use of Placement Proceeds Date: 13 November 2025 Key Highlights Successful Placement: Clearbridge Health Limited ("the Company") has completed a significant placement of 990,000,000 new ordinary…
October 6, 2025
Clearbridge Health Extends Convertible Bond Maturity: What Investors Must Know About This Strategic Move Clearbridge Health Extends Convertible Bond Maturity: What Investors Must Know About This Strategic Move Key Points for Investors Clearbridge Health Limited ("CBH") has announced a significant…
August 18, 2025
Clearbridge Health Completes Massive Share Placement and Warrant Issue Clearbridge Health Completes Massive Share Placement with Free Warrants: What Retail Investors Must Know Key Highlights from the Announcement Clearbridge Health Limited has successfully completed a major placement of 990,000,000 new…
August 18, 2025
Clearbridge Health Completes Massive Share Placement and Warrant Issue: What Retail Investors Must Know Clearbridge Health Completes Massive Share Placement and Warrant Issue: What Retail Investors Must Know Key Highlights of the Announcement Clearbridge Health Limited has finalized a major…
August 14, 2025
Clearbridge Health Announces Major Share Placement and Warrant Issue: Will This Transform the Stock's Prospects? Clearbridge Health Announces Major Share Placement and Warrant Issue: Will This Transform the Stock's Prospects? Key Highlights Massive share placement: Up to 990 million new…
August 13, 2025
Clearbridge Health Announces Major Share Placement and Free Warrants: What Investors Must Know Clearbridge Health Announces Major Share Placement and Free Warrants: What Investors Must Know Key Highlights from the Announcement Clearbridge Health Limited is launching a significant capital-raising exercise…
August 5, 2025
Clearbridge Health Launches Massive S\$1.98 Million Share Placement with Free Warrants: What Investors Must Know Key Points from the Announcement Clearbridge Health Limited plans to raise up to S\$1.98 million via a private placement of up to 990,000,000 new shares…
August 4, 2025
Clearbridge Health’s Mega Placement: Up to 49.91% Dilution, Free Warrants, and a Big Bet on Survival Clearbridge Health’s Mega Placement: Up to 49.91% Dilution, Free Warrants, and a Big Bet on Survival Key Highlights: Massive Fundraising, Free Warrants, and a…
January 10, 2025
Clearbridge Health Completes \$0.96M Share Placement; Share Count Surges to 2.17B Clearbridge Health Completes \$0.96M Share Placement; Share Count Surges to 2.17B Clearbridge Health Limited, a Singapore-based healthcare company, has successfully completed the allotment and issuance of 309,500,000 new ordinary…
December 11, 2024
Clearbridge Health's Major Share Expansion: What Investors Need to Know Clearbridge Health's Major Share Expansion: What Investors Need to Know Clearbridge Health Limited has announced a significant development in its capital structure through a renounceable non-underwritten rights issue. The company…
December 11, 2024
Clearbridge Health's Strategic Rights Issue: A Financial Game-Changer Clearbridge Health's Strategic Rights Issue: A Financial Game-Changer Clearbridge Health Limited is making a bold move with its recent announcement of a Rights Issue, which could significantly impact its share price and…
November 20, 2024
Clearbridge Health Limited Financial Analysis - Q3FY24 Clearbridge Health Limited Financial Analysis - Q3FY24 Business Description Clearbridge Health Limited is incorporated in the Republic of Singapore. The company, along with its subsidiaries, operates in the healthcare sector focusing on providing…
November 19, 2024
Clearbridge Health's Rights Issue: Strategic Move or Risky Bet? Clearbridge Health's Rights Issue: Strategic Move or Risky Bet? Clearbridge Health Limited has announced a rights issue, aiming to raise up to S\$2,308,000. This move is designed to bolster the company's…
November 19, 2024
Clearbridge Health's Bold Rights Issue: What Investors Need to Know Clearbridge Health Limited has announced a significant move aimed at bolstering its capital structure through a proposed renounceable non-underwritten rights issue of up to 1,279,125,560 new ordinary shares. This strategic…
November 19, 2024
Clearbridge Health's Strategic Rights Issue Receives Regulatory Green Light Clearbridge Health's Strategic Rights Issue Receives Regulatory Green Light Clearbridge Health Limited has achieved a significant milestone as it announces the receipt of the listing and quotation notice from the Singapore…
November 19, 2024
Clearbridge Health to Launch Major Rights Issue: What Shareholders Need to Know Clearbridge Health to Launch Major Rights Issue: What Shareholders Need to Know Clearbridge Health Limited has announced a proposed renounceable non-underwritten rights issue of up to 1,279,125,560 new…
October 29, 2024
Clearbridge Health Limited is undertaking a renounceable, non-underwritten rights issue of up to 1,279,125,560 new ordinary shares, priced at S$0.002 per share. This represents significant discounts: 53.49% off the theoretical ex-rights price of S$0.0043 and 77.78% off the VWAP of…
